Resultados de procura - Gerd Ganser
- Mostrando 1 - 20 Resultados de 25
- Go to Next Page
-
1
-
2
Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guideli... por Arnd Heiligenhaus, Martina Niewerth, Gerd Ganser, Carsten Heinz, Kirsten Minden
Publicado 2007Artigo -
3
-
4
OP0196 Changing patterns of juvenile idiopathic arthritis patients treated with etanercept from 2000 to 2016 in the german biker registry population por Gerd Horneff, Kirsten Minden, Ivan Foeldvari, Gerd Ganser, Johannes‐Peter Haas, J. Brunner, Ingrid Becker
Publicado 2017Artigo -
5
-
6
-
7
Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis por Gerd Horneff, Ariane Klein, Gerd Ganser, Michaela Sailer‐Höck, Annette Günther, Ivan Foeldvari, Frank Weller‐Heinemann
Publicado 2017Revisão -
8
-
9
-
10
THU0552 Articular and extra-articular damage in patients with juvenile idiopathic arthritis – results from the inception cohort of newly diagnosed patients with juvenile idiopathic... por Jens Klotsche, Claudia Sengler, Martina Niewerth, Jasmin Kuemmerle‐Deschner, F. Weller, Toni Hospach, Gerd Ganser, Ivan Foeldvari, Kirsten Minden
Publicado 2018Artigo -
11
THU0507 Long-term experience with adalimumab for the treatment of juvenile idiopathic arthritis. 5- year data from the german biker registry por Ariane Klein, Kirsten Minden, Ivan Foeldvari, Gerd Ganser, Johannes‐Peter Haas, Ralf Trauzeddel, Anton Hospach, Frank Weller‐Heinemann, Gerd Horneff
Publicado 2017Artigo -
12
The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception... por Claudia Sengler, Jens Klotsche, Martina Niewerth, Ina Liedmann, Dirk Föll, Arnd Heiligenhaus, Gerd Ganser, Gerd Horneff, Johannes‐Peter Haas, Kirsten Minden
Publicado 2015Artigo -
13
Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry por Gerd Horneff, Anna Carina Schulz, Jens Klotsche, Anton Hospach, Kirsten Minden, Ivan Foeldvari, Ralf Trauzeddel, Gerd Ganser, Frank Weller‐Heinemann, J.-P. Haas
Publicado 2017Artigo -
14
Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement por Gerd Horneff, Sigrid Fitter, Ivan Foeldvari, Kirsten Minden, Jasmin Kuemmerle‐Deschner, Nicolay Tzaribacev, A. Thon, Michael Borte, Gerd Ganser, Rolf Trauzeddel, Hans‐Iko Huppertz
Publicado 2012Artigo -
15
The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German... por Miriam Listing, Kirsten Mönkemöller, Ina Liedmann, Martina Niewerth, Claudia Sengler, Joachim Listing, Dirk Foell, Arnd Heiligenhaus, Ariane Klein, Gerd Horneff, Gerd Ganser, Johannes‐Peter Haas, Jens Klotsche, Kirsten Minden
Publicado 2018Artigo -
16
Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort por Claudia Sengler, Julian Zink, Jens Klotsche, Martina Niewerth, Ina Liedmann, Gerd Horneff, Christoph Kessel, Gerd Ganser, A. Thon, Johannes‐Peter Haas, Anton Hospach, Frank Weller‐Heinemann, Arnd Heiligenhaus, Dirk Foell, A. Zink, Kirsten Minden
Publicado 2018Artigo -
17
Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis por Gregor Dueckers, Nihal Guellac, Martin Arbogast, Guenther E. Dannecker, Ivan Foeldvari, Michael Frosch, Gerd Ganser, Arnd Heiligenhaus, Gerd Horneff, Arnold Illhardt, I. Kopp, R. Krauspe, Barbara Markus, H. Michels, M. Schneider, Wolfram Singendonk, H. Sitter, M. Spamer, Norbert Wagner, Tim Niehues
Publicado 2011Artigo -
18
Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi‐national survey por Ivan Foeldvari, M. Zhavania, Nina Birdi, Rubén Cuttica, Oliveira Sf, P. B. Dent, Renate Elborgh, Fabio Falcini, Gerd Ganser, H. J. Girschick, R. Häfner, Rik Joos, W. Kuis, P. Pelkonen, A. M. Prieur, K Rostropowicz-Denisiewicz, Ricardo Russo, A Savolainen, A. Siamopoulou‐Mayridou, Francesco Zulian
Publicado 2000Artigo -
19
Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany por Claas Hinze, Dirk Holzinger, Elke Lainka, Johannes‐Peter Haas, Fabian Speth, Tilmann Kallinich, Nikolaus Rieber, Markus Hufnagel, Annette Jansson, Christian M. Hedrich, Hanna Winowski, Thomas M. Berger, Ivan Foeldvari, Gerd Ganser, Anton Hospach, Hans‐Iko Huppertz, Kirsten Mönkemöller, Ulrich Neudorf, Elisabeth Weißbarth‐Riedel, Helmut Wittkowski, Gerd Horneff, Dirk Foell
Publicado 2018Artigo -
20
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis por Dragana Lazarević, Angela Pistorio, Elena Palmisani, Päivi Miettunen, Angelo Ravelli, Clarissa Pilkington, Nico Wulffraat, Clara Malattia, Stella Maris Garay, Michaël Hofer, Pierre Quartier, Pavla Doležalová, Inmaculada Calvo Penadés, Virgínia Paes Leme Ferriani, Gerd Ganser, Özgür Kasapçopur, José Melo‐Gomes, Ann M. Reed, Małgorzata Wierzbowska, Lisa G. Rider, Alberto Martini, Nicolino Ruperto
Publicado 2012Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Arthritis
Rheumatology
Physical therapy
Disease
Biology
Pediatrics
Genetics
Juvenile
Rheumatoid arthritis
Cohort
Etanercept
Immunology
Surgery
Uveitis
Adalimumab
Adverse effect
Pathology
Polyarthritis
Tocilizumab
Alternative medicine
Anakinra
Cohort study
Dermatology
Environmental health
Infliximab
Methotrexate
Oligoarthritis
Physics